A lot of news on the research front in July, which can only be good. It’s a joy, relief as well as hope that one of those research projects or trials might lead to longer periods of remission, and perhaps a return to lesser disability for those with primary and secondary forms of multiple sclerosis. So let’s keep fingers, toes, eye lashes and anything else crossed that can be crossed. A lot of people with severe MS deserve at least that. Remember, 2.3 million people with MS globally is staggering. It doesn’t have to be that way, though.
- Human Stem Cells Effectively Treat Multiple Sclerosis in Mice Models
HCPLive – Embryonic stem cells are a potentially viable treatment option for multiple sclerosis (MS), according to research published online in Stem Cell Reports.
- Innovative research tool pinpoints potential therapies for multiple sclerosis
Medical Xpress – Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100.
- Melanocortin Receptor Agonist can Treat Multiple Sclerosis
HCPLive – FRIDAY, July 11, 2014 (HealthDay News) — Melanocortin receptor type 3 (MC3) has protective properties for joint and periodontal tissues.
- Researchers discover neuroprotective role of immune cell
Medical Xpress – A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer’s disease and multiple sclerosis (MS).
- UCSF scientists identify drugs that could help MS patients
SFGate – In patients with multiple sclerosis, the immune system attacks myelin, the insulation that surrounds the wire-like connections between nerve cells.
- Scientists 1 step closer to cell therapy for multiple sclerosis patients
Medical Xpress – In multiple sclerosis, the protective covering of axons, called myelin, becomes damaged and lost.